Politiparty
Politiparty

118th Congress Health

H.R. 3100: Sickle Cell Care Expansion Act of 2023

Introduced

  1. Introduced (completed)May 5, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, May 5, 2023

This bill establishes programs to increase treatment and other services for populations with sickle cell disease. Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.

Specifically, the Department of Health and Human Services (HHS) must award grants to federally qualified health centers, community-based organizations, or other nonprofits that treat or otherwise support populations with sickle cell disease for education and advocacy programs concerning the disease. HHS must also award grants to nonprofits, including hospitals or institutions of higher education, that provide comprehensive care to populations with sickle cell disease for programs to support the transition from pediatric to adult care for patients with the disease.

Additionally, the Health Resources and Services Administration must establish a program to provide scholarships or student loan repayment awards to individuals who commit to engage in clinical practice or research related to sickle cell disease for a period of obligated service as physicians.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

8

Who scored on this bill

0 points earned

No member has earned points from it yet.

See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

History

  1. May 5, 2023Introduced in the House by Barbara Lee.
Show the full action history (3 actions)
  1. May 12, 2023Referred to the Subcommittee on Health.
  2. May 5, 2023Introduced in House
  3. May 5, 2023Referred to the House Committee on Energy and Commerce.